If you've ever tried to make an NMN gummy, you probably ran into a wall faster than you expected. It sounds easy enough: mix the powder into a sweet base, pour it into molds, and you're done. But anyone who's spent time inside a real cGMP facility knows NMN gummies are among the most technically stubborn products you can manufacture. The challenge is the environment you're asking the ingredient to live in.
The physics and chemistry inside the gummy determine whether your product will hold up on the shelf or fall apart before it ever reaches a customer.
Why NMN and gummies don't naturally get along
NMN, or Nicotinamide Mononucleotide, is a nucleotide: a nicotinamide group joined to a ribose sugar and a phosphate. In manufacturing terms, that means two things. It is hygroscopic, so it grabs moisture out of the air. It is thermally labile, so heat degrades it quickly.
Now consider what a standard gummy requires. You start with a wet slurry of gelatin or pectin, heat it to somewhere between 140°F and 190°F, then pour it into molds. The final gummy has a water activity (Aw) between 0.5 and 0.7. That's basically a warm, wet, slightly acidic sponge.
For NMN, that's hostile territory. High moisture triggers hydrolysis. High heat accelerates breakdown. And if you're using a pectin base (common for vegetarian gummies), you're working at a pH around 3.0 to 4.0. NMN is most stable near neutral pH. Drop it into that acidic gel, and it starts converting to other forms, changing the molecular profile of your finished product.
The conflict is baked into the process from the start.
The easy fix that fails cGMP
Some manufacturers try to dodge the problem entirely by dusting NMN powder onto the outside of finished gummies. This keeps the ingredient away from heat and water during cooking. But from a regulatory standpoint, it's a mess.
When you spray or dust powder onto a moving line of sticky gummies, you cannot guarantee uniform dosing. One gummy might carry 200 mg, the next only 100 mg. Under 21 CFR 111, you must establish a potency specification for the finished product and meet it in every batch. Dusting cannot meet that standard.
At KorNutra, we don't use that method. Instead, we treat NMN like the sensitive raw material it is and build the manufacturing protocol around its limitations.
How we make a stable NMN gummy
Our approach uses a two-phase process designed to protect the NMN from the environment it has to live inside.
- Phase 1: The anhydrous pre-mix. We never dissolve NMN directly into the water phase of the gummy. Instead, we create a non-aqueous suspension using a GRAS carrier, typically glycerin or an oil-based medium with near-zero water activity. This physically separates the NMN molecules from water during the early mixing stages.
- Phase 2: Late-stage injection at lower temperature. We cool the main gummy mass, whether gelatin or pectin, to below 130°F before we introduce the NMN pre-mix. Using high-shear emulsification, we micro-disperse the NMN droplets throughout the matrix. Each molecule becomes a tiny island surrounded by a protective barrier, minimizing contact with the acidic, watery gel.
The result is consistent >90% NMN retention after cook. Direct powder addition into a hot, acidic slurry routinely sacrifices a large share of the active before the batch even sets. And because we inject a liquid suspension mechanically, every gummy gets the same dose, batch after batch.
NMN's regulatory status changed in 2025
Before you commit to an NMN gummy, know where the ingredient itself stands. In late 2022, FDA concluded that NMN was excluded from the dietary supplement definition because it had been authorized for investigation as a new drug. That left the category in limbo for more than two years, even though products stayed on shelves.
In September 2025, FDA reversed that conclusion and found that NMN is not excluded from the dietary supplement definition. The agency reinforced the point in December 2025 letters to ingredient suppliers, confirming that NMN may be lawfully marketed as a dietary supplement. The Natural Products Association, which had filed a citizen petition and a lawsuit over the 2022 exclusion, dismissed its case after the reversal.
For a brand, the practical point is that an NMN gummy is now a lawful supplement format in the U.S. The constraints that remain are the label-claim rules and the stability demands of the format itself.
Regulatory boundaries you can't ignore
This part matters. Under current FDA guidance, we cannot put a statement on your label that implies NMN boosts NAD+ or slows aging. Anti-aging claims are disease claims, and only approved drugs may make them. We can list Nicotinamide Mononucleotide 150 mg on the Supplement Facts panel, and we can structure the product as a dietary supplement. But the label and marketing must stay within structure-function limits.
Also, because NMN can degrade during processing, we run full cGMP testing on every batch: heavy metals, microbial, and potency. If a gummy carries less NMN than the label claims because of thermal degradation, that is a regulatory violation. Our stability data is designed to prevent that.
The bottom line
An NMN gummy is a precision-engineered dosage form that demands respect for the raw material's chemistry. If you want a simple, cheap gummy, pick another ingredient. But if you want a stable, compliant, high-quality NMN gummy that meets label claims and passes regulatory scrutiny, the manufacturing process has to be built around the molecule, not the other way around.
At KorNutra, we design the environment around each ingredient. That's the difference between a gummy that works on paper and one that holds up on the shelf.
Ready to dig into the technical details? Contact our formulation team. We'll share the stability data and the numbers you need to make an informed decision.